Bayesian Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,300	Closed	-$41.8K	–	183
2025 Q4	$41.8K	Buy	+15,300	New	+$35.4K	0.1%	107
2025 Q2	–	Sell	-59,321	Closed	-$198K	–	710
2025 Q1	$198K	Buy	+59,321	New	+$306K	0.03%	498
2024 Q4	–	Sell	-184,400	Closed	-$1.73M	–	835
2024 Q3	$1.73M	Buy	184,400 +137,200	+291%	+$1.3M	0.2%	149
2024 Q2	$379K	Sell	47,200 -104,500	-69%	-$1.12M	0.04%	443
2024 Q1	$2.25M	Buy	151,700 +116,300	+329%	+$1.35M	0.21%	131
2023 Q4	$288K	Buy	35,400 +21,000	+146%	+$110K	0.03%	527
2023 Q3	$65.5K	Sell	14,400 -69,020	-83%	-$451K	0.01%	629
2023 Q2	$587K	Buy	+83,420	New	+$597K	0.06%	373
2022 Q3	–	Sell	-107,782	Closed	-$1.19M	–	856
2022 Q2	$1.19M	Buy	+107,782	New	+$1.41M	0.22%	121